Regulatory Filings • Aug 5, 2024
Regulatory Filings
Open in ViewerOpens in native device viewer
Aker BioMarine ASA – Feed Ingredients transaction cleared by all relevant competition authorities
Fornebu, 5 August 2024 – On 3 July 2024, Aker BioMarine ASA announced that it has entered into an agreement with American Industrial Partners and Aker Capital AS for the sale of Aker BioMarine ASA’s ownership position in the Feed Ingredients business. Closing of the transaction was subject to obtaining the necessary competition clearances.
The transaction has now been cleared by all relevant competition authorities and completion of the transaction is expected to take place during the third quarter of 2024.
For further information, please contact:
Christopher Robin Vinter, VP IR & Corporate Finance
Mobile: +47 911 60 820
Email: [email protected]
About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters of Antarctica. Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.